AbbVie Inc. — Director's Dealing 2020

Dec 31, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2020-12-29

Reporting Person: Stewart Jeffrey Ryan (EVP, Commercial Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-29	Common Stock, $0.01 par value	M	25290	$51.42	Acquired	76259	Direct
2020-12-29	Common Stock, $0.01 par value	S	25290	$105	Disposed	50969	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-29	Option (Right to buy)	$51.42	M	25290	Acquired	2024-02-19	Common stock (25290)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.01 par value	1338	Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of these securities.

F2: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.